Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide
Obesity · 2024-02 · 32 (2) · 232-233
DOI: 10.1002/oby.23941 ↗Kurz gefasst
Leserbrief in der Zeitschrift Obesity, online erschienen am 05.11.2023. Verfasst von Michael Camilleri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rocheste…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Liraglutide. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Michael Camilleri
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Camilleri, M., Carlson, P., & Dilmaghani, S. (2024). Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide. Obesity, 32(2), 232-233. https://doi.org/10.1002/oby.23941
Vancouver
Camilleri M, Carlson P, Dilmaghani S. Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide. Obesity. 2024;32(2):232-233. doi:10.1002/oby.23941
BibTeX
@article{Camilleri2024,
author = {Camilleri, Michael and Carlson, Paula and Dilmaghani, Saam},
title = {Prevalence and variations in gastric emptying delay in response to GLP ‐1 receptor agonist liraglutide},
journal = {Obesity},
year = {2024},
volume = {32},
number = {2},
pages = {232--233},
doi = {10.1002/oby.23941}
}
EUVIMED